Atlas Trials

Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers

Clinical trial NCT03805984 · COMPLETED

Trial details

NCT number
NCT03805984
Sponsor
Inovio Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lassa Fever
Start date
2019-05-09
Primary completion
2020-10-21
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.